Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Simple LC-MS/MS Method for the Quantification of PDA-66 in Human Plasma.
Schwarz R, Seiler ERD, Sender S, Pews-Davtyan A, Murua Escobar H, Zechner D, Beller M, Junghanß C, Hinz B. Schwarz R, et al. Among authors: sender s. Molecules. 2022 Feb 1;27(3):974. doi: 10.3390/molecules27030974. Molecules. 2022. PMID: 35164239 Free PMC article.
The Inhibitory Response to PI3K/AKT Pathway Inhibitors MK-2206 and Buparlisib Is Related to Genetic Differences in Pancreatic Ductal Adenocarcinoma Cell Lines.
Ma Y, Sender S, Sekora A, Kong W, Bauer P, Ameziane N, Al-Ali R, Krake S, Radefeldt M, Weiss FU, Lerch MM, Parveen A, Zechner D, Junghanss C, Murua Escobar H. Ma Y, et al. Among authors: sender s. Int J Mol Sci. 2022 Apr 13;23(8):4295. doi: 10.3390/ijms23084295. Int J Mol Sci. 2022. PMID: 35457111 Free PMC article.
Inhibitory Response to CK II Inhibitor Silmitasertib and CDKs Inhibitor Dinaciclib Is Related to Genetic Differences in Pancreatic Ductal Adenocarcinoma Cell Lines.
Ma Y, Sender S, Sekora A, Kong W, Bauer P, Ameziane N, Krake S, Radefeldt M, Al-Ali R, Weiss FU, Lerch MM, Parveen A, Zechner D, Junghanss C, Murua Escobar H. Ma Y, et al. Among authors: sender s. Int J Mol Sci. 2022 Apr 16;23(8):4409. doi: 10.3390/ijms23084409. Int J Mol Sci. 2022. PMID: 35457227 Free PMC article.
Combination of the PI3K inhibitor Idelalisib with the conventional cytostatics cytarabine and dexamethasone leads to changes in pathway activation that induce anti-proliferative effects in B lymphoblastic leukaemia cell lines.
Sklarz LM, Gladbach YS, Ernst M, Hamed M, Roolf C, Sender S, Beck J, Schütz E, Fischer S, Struckmann S, Junghanss C, Fuellen G, Murua Escobar H. Sklarz LM, et al. Among authors: sender s. Cancer Cell Int. 2020 Aug 12;20:390. doi: 10.1186/s12935-020-01431-4. eCollection 2020. Cancer Cell Int. 2020. PMID: 32817744 Free PMC article.
38 results